Evidence map›Paper›PMID 35485214›Full record

ArticleIntegrated environmental assessment and management2022

Assessment of localized and resuspended

Yasuyuki Taira, Masahiko Matsuo, Makiko Orita, Hitomi Matsunaga, Noboru Takamura, Shigekazu Hirao

Open access · hybridAbstract read
In one paragraph

Article in Integrated environmental assessment and management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yasuyuki TairaDepartment of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki City, Nagasaki Prefecture, Japan.
Masahiko MatsuoDepartment of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki City, Nagasaki Prefecture, Japan.
Makiko OritaDepartment of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki City, Nagasaki Prefecture, Japan.
Hitomi MatsunagaDepartment of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki City, Nagasaki Prefecture, Japan.
Noboru TakamuraDepartment of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki City, Nagasaki Prefecture, Japan.
Shigekazu HiraoInstitute of Environmental Radioactivity, Fukushima University, Fukushima City, Fukushima Prefecture, Japan.
Nagasaki University · JPFukushima University · JP

Funding

Research on the Health Effects of Radiation organized by the MOE, Japan No numberThe Environmental Radioactivity Research Network Center F-19-22 and F-20-17
6 · The paper itself

Abstract

As the next step that occurred more than one decade after the accident at the Fukushima Dai-ichi Nuclear Power Station (FDNPS), decontamination and demolition have been carried out in the Specified Reconstruction and Revitalization Base (SRRB) of the difficult-to-return zone around the FDNPS. However, the risk of internal exposure among workers due to airborne dust inhalation after building demolition operations has not been sufficiently evaluated. To evaluate the working environment and internal exposure risk due to inhalation in the SRRB of Tomioka town, Fukushima Prefecture, the cesium-137 (

Indexed as

Fukushima Nuclear AccidentRadiation MonitoringCesium RadioisotopesDecontaminationDustHumansJapanCesium-137Cesium RadioisotopesDustDemolitionDifficult-to-return zoneInternal exposureRadiocesiumResuspension

Identifiers

PMID35485214
PMCPMC9790190
OpenAlexW4225132553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.